$WHWK (WHITEHAWK THERAPEUTICS) — 8-K: Whitehawk Therapeutics appoints former Incyte executive Vijay Iyengar, MD, to Board

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK) appointed Vijay Iyengar, MD, to its Board of Directors, effective September 9, 2026. Dr. Iyengar brings more than two decades of oncology experience, including nine years in senior leadership roles at Incyte Corporation, where he helped drive growth from approximately $1B to more than $4B in annual revenue. His appointment supports Whitehawk’s efforts to advance its clinical programs and expand its ADC portfolio.

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK) appointed Vijay Iyengar, MD, to its Board of Directors, effective September 9, 2026. Dr. Iyengar brings more than two decades of oncology experience, includ